Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR

Documenti analoghi

• JUN-Mediated downregulation of EGFR signaling is associated with resistance to gefitinib in EGFR-mutant NSCLC cell lines
  di: Kani, Kian, et al.
  Pubblicazione: (2017)
• Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC “capitulate”?
  di: Ko, Brian, et al.
  Pubblicazione: (2018)
• The Dissociation of Gefitinib Trough Concentration and Clinical Outcome in NSCLC Patients with EGFR Sensitive Mutations
  di: Xin, Shuang, et al.
  Pubblicazione: (2015)
• Acquired Gefitinib-Resistant Mutation of EGFR in a Chemonaive Lung Adenocarcinoma Harboring Gefitinib-Sensitive Mutation L858R
  di: Gow, Chien-Hung, et al.
  Pubblicazione: (2005)
• RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC
  di: Makoto Nishio, MD, PhD, et al.
  Pubblicazione: (2022-04-01)